These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 26275318)

  • 21. Editorial overview: Vaccines: Vaccines for cancer and infectious diseases.
    Mascola JR; Ahmed R
    Curr Opin Immunol; 2015 Aug; 35():v-vii. PubMed ID: 26275318
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention of cancer through immunization: Prospects and challenges for the 21st century.
    Frazer IH; Lowy DR; Schiller JT
    Eur J Immunol; 2007 Nov; 37 Suppl 1():S148-55. PubMed ID: 17972339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor vaccines--a reality at last?
    Hellström I; Hellström KE
    J Immunother; 1998 Mar; 21(2):119-26. PubMed ID: 9551363
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytokine adjuvants for vaccine therapy of neoplastic and infectious disease.
    Decker WK; Safdar A
    Cytokine Growth Factor Rev; 2011 Aug; 22(4):177-87. PubMed ID: 21862380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developments in virus-like particle-based vaccines for infectious diseases and cancer.
    Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM
    Expert Rev Vaccines; 2011 Nov; 10(11):1569-83. PubMed ID: 22043956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA/genetic vaccination (minireview).
    Kucerova L
    Viral Immunol; 1998; 11(2):55-63. PubMed ID: 9765027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live attenuated vaccines: Historical successes and current challenges.
    Minor PD
    Virology; 2015 May; 479-480():379-92. PubMed ID: 25864107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Embryonic vaccines against cancer: an early history.
    Brewer BG; Mitchell RA; Harandi A; Eaton JW
    Exp Mol Pathol; 2009 Jun; 86(3):192-7. PubMed ID: 19171137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer vaccines: current status and future potential.
    Doehn C; Böhmer T; Kausch I; Sommerauer M; Jocham D
    BioDrugs; 2008; 22(2):71-84. PubMed ID: 18345705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoprevention--history and general principles.
    Wu X; Patterson S; Hawk E
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):445-59. PubMed ID: 22122762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilizing bacterial flagellins against infectious diseases and cancers.
    Tarahomjoo S
    Antonie Van Leeuwenhoek; 2014 Feb; 105(2):275-88. PubMed ID: 24276957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A short history of research on immunity to infectious diseases in fish.
    Van Muiswinkel WB; Nakao M
    Dev Comp Immunol; 2014 Apr; 43(2):130-50. PubMed ID: 23994237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Live porcine reproductive and respiratory syndrome virus vaccines: Current status and future direction.
    Renukaradhya GJ; Meng XJ; Calvert JG; Roof M; Lager KM
    Vaccine; 2015 Aug; 33(33):4069-80. PubMed ID: 26148878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbohydrate-based vaccines: challenges and opportunities.
    Huang YL; Wu CY
    Expert Rev Vaccines; 2010 Nov; 9(11):1257-74. PubMed ID: 21087106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA vaccines: successes and limitations in cancer and infectious disease.
    Lowe DB; Shearer MH; Kennedy RC
    J Cell Biochem; 2006 May; 98(2):235-42. PubMed ID: 16440328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic vaccines for human papillomaviruses.
    Gissmann L; Osen W; Müller M; Jochmus I
    Intervirology; 2001; 44(2-3):167-75. PubMed ID: 11509878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rationale for prophylactic cancer vaccines and need for a paradigm shift.
    Sobol RE
    Cancer Gene Ther; 2006 Aug; 13(8):725-31. PubMed ID: 16543919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oncolytic enteroviruses].
    Chumakov PM; Morozova VV; Babkin IV; Baĭkov IK; Netesov SV; Tikunova NV
    Mol Biol (Mosk); 2012; 46(5):712-25. PubMed ID: 23156670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heat shock proteins as vaccine adjuvants in infections and cancer.
    Segal BH; Wang XY; Dennis CG; Youn R; Repasky EA; Manjili MH; Subjeck JR
    Drug Discov Today; 2006 Jun; 11(11-12):534-40. PubMed ID: 16713905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rational design of vaccines: learning from immune evasion mechanisms of persistent viruses and tumors.
    Arens R
    Adv Immunol; 2012; 114():217-43. PubMed ID: 22449784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.